At the time of writing, BioAtla Inc [BCAB] stock is trading at $0.78, down -6.11%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BCAB shares have gain 4.04% over the last week, with a monthly amount drifted -7.86%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
BioAtla Inc [NASDAQ: BCAB] stock has seen the most recent analyst activity on August 13, 2025, when Citizens JMP downgraded its rating to a Mkt Perform. Previously, H.C. Wainwright downgraded its rating to Neutral on November 13, 2024. On September 15, 2022, JMP Securities initiated with a Mkt Outperform rating and assigned a price target of $17 on the stock. Credit Suisse downgraded its rating to a Neutral and decreased its price target to $5 on May 05, 2022. H.C. Wainwright initiated its recommendation with a Buy and recommended $25 as its price target on March 21, 2022. In a note dated June 28, 2021, ROTH Capital initiated a Buy rating and provided a target price of $75 on this stock.
For the past year, the stock price of BioAtla Inc fluctuated between $0.24 and $1.43. Currently, Wall Street analysts expect the stock to reach $5 within the next 12 months. BioAtla Inc [NASDAQ: BCAB] shares were valued at $0.78 at the most recent close of the market. An investor can expect a potential return of 541.03% based on the average BCAB price forecast.
Analyzing the BCAB fundamentals
According to BioAtla Inc [NASDAQ:BCAB], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. To continue investigating profitability, this company’s Return on Assets is posted at -3.08, Equity is 5.9 and Total Capital is 31.93. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.2.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.7599 points at the first support level, and at 0.7361 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.8213, and for the 2nd resistance point, it is at 0.8589.
Ratios To Look Out For
It is important to note that BioAtla Inc [NASDAQ:BCAB] has a current ratio of 0.54. In addition, the Quick Ratio stands at 0.54 and the Cash Ratio stands at 0.46.
